SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-19-000381
Filing Date
2019-02-12
Accepted
2019-02-12 09:04:27
Documents
1
Group Members
CLAL INDUSTRIES LTD.CLAL LIFE SCIENCES L.P

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk1922608.htm SC 13G/A 108623
  Complete submission text file 0001178913-19-000381.txt   110176
Mailing Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023
Business Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023 972-3-6075794
Clal Biotechnology Industries Ltd. (Filed by) CIK: 0001468950 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Subject) CIK: 0001593984 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88069 | Film No.: 19587848
SIC: 2833 Medicinal Chemicals & Botanical Products